Clinical Trials Directory

Trials / Completed

CompletedNCT05084599

Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section

Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section:A Non-inferiority Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
124 (actual)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

For hypotension after spinal anesthesia, metaraminol has different 90% effective doses in the supine position and the left-tilt position. We plan to conduct a non-inferiority trial to compare the effects of the two on the fetus and the mother.

Conditions

Interventions

TypeNameDescription
DRUGMetaraminol 2.7μg/kg/minAfter spinal anesthesia, the patient was placed in a supine position until the fetus was delivered, and metaraminol was given at an initial rate of 2.7μg/kg/min throughout the process.
DRUGMetaraminol 2μg/kg/minAfter spinal anesthesia, the patient was placed in left-tilt position until the fetus was delivered, and metaraminol was given at an initial rate of 2μg/kg/min throughout the process.

Timeline

Start date
2022-05-12
Primary completion
2024-01-31
Completion
2024-01-31
First posted
2021-10-20
Last updated
2024-02-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05084599. Inclusion in this directory is not an endorsement.